SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
SINGAPORE, Jan. 19, 2026 /PRNewswire/ -- LANDI Global, a world leader in payment and merchant professional solutions, is proud to mark its 20th anniversary...
HONG KONG, Jan. 19, 2026 /PRNewswire/ -- Mu Digital, a Web3 platform bringing Asia's credit markets onchain, announced the launch of its multi-month incentive...
Designation underscores potential of chemically induced, off-the-shelf cell therapy to address high unmet need in Parkinson's disease, following compelling Phase I clinical data ...